Blog 
Whistleblowers
- Whistleblower Claims She Was Asked to Falsify Grades At Charter School
- Medicare & Medicaid Fraud Whistleblower Suit Settled for $137.5 Million
- Lockheed Martin Pricing Fraud Whistleblower Suits Settled for $15.9 Million
- Whistleblower's Retaliation Suit Reinstated by Appeals Court
- Misreported Drug Prices Yield $11 Million Settlement in Whistleblower Case
J & J Risperdal Whistleblower Suit Settled for $158 Million
A whistleblower suit against Johnson & Johnson (J & J) involving its anti-psychotic drug, Risperdal, has been settled for $158 million. The suit claimed that J & J overcharged Medicaid for the drug and wrongfully promoted it including for use by children. The whistleblower, Allen Jones, a former investigator for the Pennsylvania Office of Inspector General, reported as follows: "There were many trials with negative information that the company completely buried. They did not forward it to the FDA. They denied it even existed. Then, on a state-by-state level, they infiltrated the mental health delivery system."Source: Boston Herald
The whistleblower suit was brought under the federal False Claims Act, which allows lawsuits by whistleblowers where a supplier or contractor to the government has overcharged it, deceived it or defrauded it in some way. Whistleblowers in suits under the False Claims Act may retain 15-25% of the money recovered.
Lexington, Kentucky whistleblower lawyer Robert Abell represents whistleblowers in suits under the False Claims Act; contact him at 859-254-7076.
Category: General
There are no comments.
Post a comment
Post a Comment to "J & J Risperdal Whistleblower Suit Settled for $158 Million"
To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."Free Consultation
Robert Abell
120 North Upper Street
Lexington, KY 40507
Phone: (859) 254-7076
Fax: (859) 281-6541
Get Directions
